- Home
- TLSI vs FINW Comparison
TLSI vs FINW Comparison
Compare TLSI & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- FINW
- Stock Information
- Founded
- TLSI 2010
- FINW 1999
- Country
- TLSI United States
- FINW United States
- Employees
- TLSI N/A
- FINW N/A
- Industry
- TLSI Medical Specialities
- FINW Commercial Banks
- Sector
- TLSI Health Care
- FINW Finance
- Exchange
- TLSI Nasdaq
- FINW Nasdaq
- Market Cap
- TLSI 124.9M
- FINW 212.8M
- IPO Year
- TLSI N/A
- FINW 2021
- Fundamental
- Price
- TLSI $4.69
- FINW $15.33
- Analyst Decision
- TLSI Strong Buy
- FINW Buy
- Analyst Count
- TLSI 6
- FINW 3
- Target Price
- TLSI $11.75
- FINW $18.67
- AVG Volume (30 Days)
- TLSI 36.4K
- FINW 19.3K
- Earning Date
- TLSI 11-14-2024
- FINW 01-30-2025
- Dividend Yield
- TLSI N/A
- FINW N/A
- EPS Growth
- TLSI N/A
- FINW N/A
- EPS
- TLSI N/A
- FINW 1.06
- Revenue
- TLSI $26,891,000.00
- FINW $69,509,000.00
- Revenue This Year
- TLSI $60.96
- FINW N/A
- Revenue Next Year
- TLSI $53.65
- FINW $10.13
- P/E Ratio
- TLSI N/A
- FINW $14.71
- Revenue Growth
- TLSI 67.90
- FINW 4.87
- 52 Week Low
- TLSI $3.50
- FINW $8.72
- 52 Week High
- TLSI $10.42
- FINW $20.50
- Technical
- Relative Strength Index (RSI)
- TLSI 51.68
- FINW 35.07
- Support Level
- TLSI $4.72
- FINW $15.51
- Resistance Level
- TLSI $5.32
- FINW $16.65
- Average True Range (ATR)
- TLSI 0.31
- FINW 0.71
- MACD
- TLSI 0.01
- FINW -0.07
- Stochastic Oscillator
- TLSI 47.52
- FINW 0.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank also has established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.